【ChiCTR2200056183】Hajibandeh Index versus NELA Score in Predicting Mortality Following Emergency Laparotomy: a medical records based study
ChiCTR2200056183
结束
/
/
/
2022-02-01
/
/
Acute abdominal pathology requiring emergency laparotomy
Hajibandeh Index versus NELA Score in Predicting Mortality Following Emergency Laparotomy: a medical records based study
Predictive Significance of Hajibandeh Index
CF72 8XR
Emergency laparotomy carries a high risk of morbidity and mortality.1 Modern predictors of mortality following emergency laparotomy include age over 80, American Society of Anesthesiologists (ASA) status above 3, sarcopenia (age-related loss of skeletal muscle mass), presence of intraperitoneal contamination, and the need for a bowel resection.2-4 In order to identify patients at high risk of morbidity and mortality following emergency laparotomy, there has been increasing effort to develop and validate accurate risk-prediction models over recent years. An accurate risk-prediction model would facilitate the preoperative risk assessment, the prediction of the need for perioperative support in critical care units, objective discussion between patients and relatives and multidisciplinary decision making when deciding on operative or non-operative treatment high risk patients. Commonly used risk-prediction models for predicating mortality following emergency laparotomy include the Portsmouth-physiological and operative severity score for the enumeration of mortality and morbidity (P-POSSUM)5 and the National Emergency Laparotomy Audit (NELA) score.6 Although P-POSSUM was initially the most commonly used model for predicting mortality following emergency laparotomy,7 it lost its popularity due to concerns about inaccuracy in some subgroups of patients and potential overestimation of mortality.8,9 The predictive value of the NELA score and P-POSSUM model have been compared recently and the routine use of NELA model instead of P-POSSUM has been recommended.10,11 The Hajibandeh Index (HI), which is derived from combined levels of C-reactive protein (CRP), lactate, neutrophils, lymphocytes and albumin, was developed and validated in our previous studies.12,13 It was shown that HI predicts the presence of intraperitoneal contamination in patients with acute abdominal pathology and postoperative mortality in patients undergoing emergency laparotomy.12 The HI includes levels of CRP, neutrophils and lactate as nominator considering the fact that their levels increase in presence of abdominal sepsis. It includes levels of albumin and lymphocytes as denominators because their levels decrease in presence of abdominal sepsis.12, 13 In this study we aimed to compare the performance of the HI and NELA model in predicting postoperative mortality in patients undergoing emergency laparotomy. Moreover, we aimed to reassess the performance of HI in predicting the nature and presence of peritoneal contamination.
连续入组
回顾性研究
Not applicable as the study was retrospective cohort study
N/A
This research receives no specific grant from any funding agency in the public, commercial, or not-for-profit organisations.
/
700
/
2021-11-01
2021-12-31
/
All patients aged over 18 who underwent emergency laparotomy in our centre between January 2014 to January 2021 were considered eligible for inclusion. The indications of interest for emergency laparotomy included small bowel obstruction, large bowel obstruction, visceral perforation, intestinal ischaemia, intraabdominal collection, intraabdominal bleeding, and intraabdominal sepsis of any source (anastomotic leak, colitis, intestinal fistula). The list of procedures of interest during emergency laparotomy was not exhaustive and included colectomies, small bowel resection, repair of perforated viscus, adhesiolysis, creation of defunctioning stoma, achievement of haemostasis, drainage of intraabdominal collection and peritoneal irrigation.;
请登录查看The patients who underwent laparotomy secondary to trauma were excluded. Moreover, patients who did not have available preoperative levels of CRP, neutrophils, lactate, lymphocytes or albumin and the patients with underlying haematological malignancy resulting in chronic elevated levels of neutrophils or lymphocytes were excluded.;
请登录查看Shahab Hajibandeh- Department of General Surgery, Royal Glamorgan Hospital
CF243AG
Shahab Hajibandeh- Department of General Surgery, Royal Glamorgan Hospital的其他临床试验
英国皇家格那摩根医院的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

